Press Releases Novavax, Inc.

Equities

NVAX

US6700024010

Real-time Estimate Cboe BZX Other stock markets 02:20:52 2024-06-06 pm EDT			5-day change	1st Jan Change
19.74 ^USD	-5.89%		+28.33%	+307.71%

06:46pm	Wall Street mixed as Nvidia retreat hits tech stocks; payrolls data in focus	RE
06:27pm	Novavax Says FDA Review Target Date Set for Covid-19 Vaccine Biologics License Application	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novavax Prepared to Deliver JN.1 Protein-based Non-mRNA COVID-19 Vaccine This Fall Consistent with U.S. FDA VRBPAC Recommendation	10:20am	AQ
Peraso Inc. (NASDAQ: PRSO) Announces Paradigm-Shifting mmWave Wi-Fi Advancements with Phased Array Antenna Technology	07:49am	AQ
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines	07:33pm	AQ
Novavax : Prepared to Deliver JN.1 Protein based Non mRNA COVID 19 Vaccine This Fall Consistent with U.S. FDA VRBPAC Recommendation	Jun. 05	PU
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns	May. 30	AQ
Novavax to Participate in 2024 Jefferies Global Healthcare Conference	May. 30	PR
Serum Institute of India Ships Its First Set of R21/Matrix-M? Malaria Vaccine Doses to Africa [press release]	May. 20	AQ
Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting	May. 20	AQ
Novavax to Participate in BofA Securities 2024 Health Care Conference	May. 13	PR
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines	May. 13	AQ
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights	May. 13	AQ
Q1 2024 Earnings presentation	May. 10	PU
Novavax: Q1 Earnings Snapshot	May. 10	AQ
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights	May. 10	PR
Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024	May. 07	PR
Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting	May. 06	AQ
Novavax : Prepared to Deliver Protein-based Non-mRNA JN.1 COVID-19 Vaccine in Line with WHO Recommendation this Fall	Apr. 26	PU
Novavax : to Supply Updated COVID-19 Vaccine to Private Healthcare Providers in the United Kingdom	Apr. 18	PU
Shah Capital nominates two highly qualified independent director candidates for Novavax	Apr. 15	AQ
Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024	Apr. 01	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Novavax Surges on $1.2 Billion Sanofi Vaccine Deal

May 10, 2024 at 02:52 pm EDT